8-133542766-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_173344.3(ST3GAL1):c.-429+3008T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.62 ( 29410 hom., cov: 19)
Consequence
ST3GAL1
NM_173344.3 intron
NM_173344.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.502
Publications
1 publications found
Genes affected
ST3GAL1 (HGNC:10862): (ST3 beta-galactoside alpha-2,3-sialyltransferase 1) The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi but can be proteolytically processed to a soluble form. Correct glycosylation of the encoded protein may be critical to its sialyltransferase activity. This protein, which is a member of glycosyltransferase family 29, can use the same acceptor substrates as does sialyltransferase 4B. Two transcript variants encoding the same protein have been found for this gene. Other transcript variants may exist, but have not been fully characterized yet. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ST3GAL1 | NM_173344.3 | c.-429+3008T>C | intron_variant | Intron 2 of 9 | ENST00000522652.6 | NP_775479.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.619 AC: 87616AN: 141466Hom.: 29379 Cov.: 19 show subpopulations
GnomAD3 genomes
AF:
AC:
87616
AN:
141466
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.620 AC: 87672AN: 141508Hom.: 29410 Cov.: 19 AF XY: 0.622 AC XY: 42402AN XY: 68220 show subpopulations
GnomAD4 genome
AF:
AC:
87672
AN:
141508
Hom.:
Cov.:
19
AF XY:
AC XY:
42402
AN XY:
68220
show subpopulations
African (AFR)
AF:
AC:
31977
AN:
37304
American (AMR)
AF:
AC:
8383
AN:
13994
Ashkenazi Jewish (ASJ)
AF:
AC:
1992
AN:
3414
East Asian (EAS)
AF:
AC:
4459
AN:
4764
South Asian (SAS)
AF:
AC:
2894
AN:
4446
European-Finnish (FIN)
AF:
AC:
3770
AN:
8316
Middle Eastern (MID)
AF:
AC:
161
AN:
284
European-Non Finnish (NFE)
AF:
AC:
32540
AN:
66166
Other (OTH)
AF:
AC:
1172
AN:
1930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1327
2654
3981
5308
6635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2754
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.